Clinical trial
Immunotherapy for Patients With Renal Cell Carcinoma
NCT00176501 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunotherapy for Patients With Renal Cell Carcinoma
- Lead sponsor
- Rutgers, The State University of New Jersey
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- August 31, 2004
- Completion date
- August 31, 2008
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
kidney cancer